We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCC
2251
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$473K ﹤0.01%
12,103
-2,550
-17% -$97.2K
EVBG
2252
DELISTED
Everbridge, Inc. Common Stock
EVBG
$470K ﹤0.01%
15,812
-3,029
-16% -$82.5K
BL icon
2253
BlackLine
BL
$1.84B
$469K ﹤0.01%
14,298
-956
-6% -$33.5K
EVC icon
2254
Entravision Communication
EVC
$1.03B
$469K ﹤0.01%
65,555
-15,102
-19% -$94.7K
NEO icon
2255
NeoGenomics
NEO
$2.02B
$469K ﹤0.01%
52,975
-9,400
-15% -$86.7K
PDLI
2256
DELISTED
PDL BioPharma, Inc.
PDLI
$469K ﹤0.01%
171,116
-37,230
-18% -$114K
RBCAA icon
2257
Republic Bancorp
RBCAA
$1.95B
$468K ﹤0.01%
12,318
-1,785
-13% -$71.7K
EIGI
2258
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$466K ﹤0.01%
55,488
-10,814
-16% -$91.4K
AGYS icon
2259
Agilysys
AGYS
$2.98B
$465K ﹤0.01%
37,851
+4,761
+14% +$58.2K
COLL icon
2260
Collegium Pharmaceutical
COLL
$1.14B
$465K ﹤0.01%
25,183
-2,450
-9% -$35.1K
ZEUS
2261
DELISTED
Olympic Steel
ZEUS
$465K ﹤0.01%
21,648
+3,592
+20% +$73.2K
HTB
2262
HomeTrust Bancshares
HTB
$863M
$465K ﹤0.01%
18,054
-3,026
-14% -$79.5K
NIC icon
2263
Nicolet Bankshares
NIC
$3.59B
$464K ﹤0.01%
8,472
-1,599
-16% -$92.2K
REGI
2264
DELISTED
Renewable Energy Group, Inc.
REGI
$464K ﹤0.01%
39,355
-6,737
-15% -$77.8K
ZAGG
2265
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$461K ﹤0.01%
24,985
-4,806
-16% -$89.9K
APTI
2266
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$461K ﹤0.01%
19,619
-596
-3% -$12.7K
RIGL icon
2267
Rigel Pharmaceuticals
RIGL
$682M
$459K ﹤0.01%
11,829
-2,359
-17% -$89.8K
AQUA
2268
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$459K ﹤0.01%
+19,375
New +$427K
NCMI icon
2269
National CineMedia
NCMI
$370M
$455K ﹤0.01%
6,634
-1,104
-14% -$73.3K
KLDX
2270
DELISTED
KLONDEX MINES LTD
KLDX
$455K ﹤0.01%
174,412
-31,435
-15% -$89.9K
FOR icon
2271
Forestar Group
FOR
$1.44B
$454K ﹤0.01%
20,627
-65,012
-76% -$1.26M
MSBI icon
2272
Midland States Bancorp
MSBI
$698M
$454K ﹤0.01%
13,970
-2,739
-16% -$89.1K
GBLI icon
2273
Global Indemnity Group
GBLI
$402M
$453K ﹤0.01%
10,791
-1,520
-12% -$64.7K
LOB icon
2274
Live Oak Bancshares
LOB
$1.97B
$452K ﹤0.01%
18,967
-2,422
-11% -$58.5K
BV
2275
DELISTED
Bazaarvoice, Inc.
BV
$450K ﹤0.01%
82,582
-14,030
-15% -$70.8K

Similar funds

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.